ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 224 filers reported holding ACADIA PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 0.68 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $35,033,124 | -9.5% | 1,681,052 | +4.0% | 1.70% | +0.2% |
| Q2 2023 | $38,726,000 | +37.5% | 1,616,952 | +8.0% | 1.69% | +25.4% |
| Q1 2023 | $28,165,259 | +33.8% | 1,496,560 | +13.2% | 1.35% | +32.8% |
| Q4 2022 | $21,048,564 | -3.2% | 1,322,146 | -0.6% | 1.02% | -9.4% |
| Q3 2022 | $21,753,000 | +79.4% | 1,329,626 | +54.5% | 1.12% | +79.8% |
| Q2 2022 | $12,128,000 | -36.5% | 860,749 | +9.1% | 0.62% | -14.3% |
| Q1 2022 | $19,103,000 | +14.1% | 788,738 | +10.0% | 0.73% | +17.8% |
| Q4 2021 | $16,742,000 | – | 717,318 | – | 0.62% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Finepoint Capital LP | 556,553 | $11,598,565 | 5.78% |
| Baker Brothers Advisors | 42,864,612 | $893,298,514 | 5.15% |
| RTW INVESTMENTS, LP | 11,576,537 | $241,255,031 | 5.09% |
| Palo Alto Investors LP | 2,405,793 | $50,136,726 | 4.74% |
| Birchview Capital, LP | 240,400 | $5,009,936 | 4.26% |
| EcoR1 Capital, LLC | 5,991,479 | $124,862,422 | 4.21% |
| EMERALD ADVISERS, LLC | 1,681,052 | $35,033,124 | 1.70% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 1,303,988 | $27,175,110 | 1.64% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 179,702 | $3,739,599 | 1.26% |
| SECTOR GAMMA AS | 179,785 | $3,746,719 | 0.96% |